These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 11134507)

  • 61. Accutin, a new disintegrin, inhibits angiogenesis in vitro and in vivo by acting as integrin alphavbeta3 antagonist and inducing apoptosis.
    Yeh CH; Peng HC; Huang TF
    Blood; 1998 Nov; 92(9):3268-76. PubMed ID: 9787163
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Identification of CD47/integrin-associated protein and alpha(v)beta3 as two receptors for the alpha3(IV) chain of type IV collagen on tumor cells.
    Shahan TA; Ziaie Z; Pasco S; Fawzi A; Bellon G; Monboisse JC; Kefalides NA
    Cancer Res; 1999 Sep; 59(18):4584-90. PubMed ID: 10493512
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Alpha(v)beta3 and alpha(v)beta5 integrin expression in meningiomas.
    Bello L; Zhang J; Nikas DC; Strasser JF; Villani RM; Cheresh DA; Carroll RS; Black PM
    Neurosurgery; 2000 Nov; 47(5):1185-95. PubMed ID: 11063113
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Serine 752 in the cytoplasmic domain of the beta 3 integrin subunit is not required for alpha v beta 3 postreceptor signaling events.
    Kieffer N; Melchior C; Guinet JM; Michels S; Gouon V; Bron N
    Cell Adhes Commun; 1996 Jul; 4(1):25-39. PubMed ID: 8870971
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Baicalein and baicalin are potent inhibitors of angiogenesis: Inhibition of endothelial cell proliferation, migration and differentiation.
    Liu JJ; Huang TS; Cheng WF; Lu FJ
    Int J Cancer; 2003 Sep; 106(4):559-565. PubMed ID: 12845652
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9.
    Sun LC; Luo J; Mackey LV; Fuselier JA; Coy DH
    Cancer Lett; 2007 Feb; 246(1-2):157-66. PubMed ID: 16644105
    [TBL] [Abstract][Full Text] [Related]  

  • 67. IS20I, a specific alphavbeta3 integrin inhibitor, reduces glioma growth in vivo.
    Bello L; Lucini V; Giussani C; Carrabba G; Pluderi M; Scaglione F; Tomei G; Villani R; Black PM; Bikfalvi A; Carroll RS
    Neurosurgery; 2003 Jan; 52(1):177-85; discussion 185-6. PubMed ID: 12493116
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Significance of RGD loop and C-terminal domain of echistatin for recognition of alphaIIb beta3 and alpha(v) beta3 integrins and expression of ligand-induced binding site.
    Marcinkiewicz C; Vijay-Kumar S; McLane MA; Niewiarowski S
    Blood; 1997 Aug; 90(4):1565-75. PubMed ID: 9269775
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Contortrostatin, a dimeric disintegrin from Agkistrodon contortrix contortrix, inhibits breast cancer progression.
    Zhou Q; Sherwin RP; Parrish C; Richters V; Groshen SG; Tsao-Wei D; Markland FS
    Breast Cancer Res Treat; 2000 Jun; 61(3):249-60. PubMed ID: 10966001
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Multiple roles for platelet GPIIb/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis.
    Trikha M; Zhou Z; Timar J; Raso E; Kennel M; Emmell E; Nakada MT
    Cancer Res; 2002 May; 62(10):2824-33. PubMed ID: 12019160
    [TBL] [Abstract][Full Text] [Related]  

  • 71. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
    Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
    Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice.
    Reinmuth N; Liu W; Ahmad SA; Fan F; Stoeltzing O; Parikh AA; Bucana CD; Gallick GE; Nickols MA; Westlin WF; Ellis LM
    Cancer Res; 2003 May; 63(9):2079-87. PubMed ID: 12727823
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Novel approach to analysis of in vitro tumor angiogenesis with a variable-pressure scanning electron microscope: suppression by matrix metalloproteinase inhibitor SI-27.
    Yoshida D; Noha M; Watanabe K; Sugisaki Y; Teramoto A
    Brain Tumor Pathol; 2001; 18(2):89-100. PubMed ID: 11908879
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Alpha-V-dependent outside-in signaling is required for the regulation of CD44 surface expression, MMP-2 secretion, and cell migration by osteopontin in human melanoma cells.
    Samanna V; Wei H; Ego-Osuala D; Chellaiah MA
    Exp Cell Res; 2006 Jul; 312(12):2214-30. PubMed ID: 16631740
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Involvement of alpha(v)beta3 integrin-like receptor and glycosaminoglycans in Candida albicans germ tube adhesion to vitronectin and to a human endothelial cell line.
    Santoni G; Spreghini E; Lucciarini R; Amantini C; Piccoli M
    Microb Pathog; 2001 Oct; 31(4):159-72. PubMed ID: 11562169
    [TBL] [Abstract][Full Text] [Related]  

  • 76. BAY 12-9566, a novel inhibitor of matrix metalloproteinases with antiangiogenic activity.
    Gatto C; Rieppi M; Borsotti P; Innocenti S; Ceruti R; Drudis T; Scanziani E; Casazza AM; Taraboletti G; Giavazzi R
    Clin Cancer Res; 1999 Nov; 5(11):3603-7. PubMed ID: 10589777
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Matrix metalloproteinase/integrin interactions as target for anti-angiogenic treatment strategies.
    Kessler TA; Pfeifer A; Silletti S; Mesters RM; Berdel WE; Verma I; Cheresh D
    Ann Hematol; 2002; 81 Suppl 2():S69-70. PubMed ID: 12611083
    [TBL] [Abstract][Full Text] [Related]  

  • 78. SI-27, a novel inhibitor of matrix metalloproteinases with antiangiogenic activity: detection with a variable-pressure scanning electron microscope.
    Yoshida D; Noha M; Watanabe K; Sugisaki Y; Teramoto A
    Neurosurgery; 2002 Mar; 50(3):578-86; discussion 586-8. PubMed ID: 11841727
    [TBL] [Abstract][Full Text] [Related]  

  • 79. SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors.
    Laird AD; Vajkoczy P; Shawver LK; Thurnher A; Liang C; Mohammadi M; Schlessinger J; Ullrich A; Hubbard SR; Blake RA; Fong TA; Strawn LM; Sun L; Tang C; Hawtin R; Tang F; Shenoy N; Hirth KP; McMahon G; Cherrington
    Cancer Res; 2000 Aug; 60(15):4152-60. PubMed ID: 10945623
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Alpha(v)beta3 and alpha(v)beta5 integrins bind both the proximal RGD site and non-RGD motifs within noncollagenous (NC1) domain of the alpha3 chain of type IV collagen: implication for the mechanism of endothelia cell adhesion.
    Pedchenko V; Zent R; Hudson BG
    J Biol Chem; 2004 Jan; 279(4):2772-80. PubMed ID: 14610079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.